Skip to main content

Advertisement

Log in

Implantable Gastric Stimulation for the Treatment of Severe Obesity

  • Published:
Obesity Surgery Aims and scope Submit manuscript

The prevalence of obesity is growing worldwide at an alarming rate. Current medical therapies are often ineffective and surgical treatments result in weight loss but have significant risk. Implantable Gastric Stimulation (IGS®) offers a novel approach to weight loss. Simply stated, the IGS system electrically stimulates the stomach with a pacemaker-like device. The device is implanted in a brief minimally invasive procedure. Investigation in over 500 patients globally has proven it to be safe and seemly free of long-term sequelae. With refinements in patient selection and device application, the weight loss results have been steadily improving. The IGS may someday become a reliable and safe surgical option for weight loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shikora, S.A. Implantable Gastric Stimulation for the Treatment of Severe Obesity. OBES SURG 14, 545–548 (2004). https://doi.org/10.1381/096089204323013596

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1381/096089204323013596

Navigation